Anticancer Drug Development

Here in a single source is a complete spectrum of ideas on the development of new anticancer drugs. Containing concise reviews of multidisciplinary fields of research, this book offers a wealth of ideas on current and future molecular targets for drug design, including signal transduction, the cell division cycle, and programmed cell death. Detailed descriptions of sources for new drugs and methods for testing and clinical trial design are also provided.

• One work that can be consulted for all aspects of anticancer drug development
• Concise reviews of research fields, combined with practical scientific detail, written by internationally respected experts
• A wealth of ideas on current and future molecular targets for drug design, including signal transduction, the cell division cycle, and programmed cell death
• Detailed descriptions of the sources of new anticancer drugs, including combinatorial chemistry, phage display, and natural products
• Discussion of how new drugs can be tested in preclinical systems, including the latest technology of robotic assay systems, cell culture, and experimental animal techniques
• Hundreds of references that allow the reader to access relevant scientific and medical literature
• Clear illustrations, some in color, that provide both understanding of the field and material for teaching

Bruce C. Baguley, The University of Auckland, Auckland, New Zealand
David Kerr, CRC Institute for Cancer Medicine, University of Oxford, Oxford, U.K.